Stains & CD markers
Progesterone receptor (PR)

Last author update: 1 January 2013
Last staff update: 11 November 2021

Copyright: 2002-2023,, Inc.

PubMed Search: Progesterone receptor [title]

Nat Pernick, M.D.
Page views in 2022: 5,265
Page views in 2023 to date: 2,615
Cite this page: Pernick N. Progesterone receptor. website. Accessed June 4th, 2023.
Definition / general
Uses by pathologists
  • In breast cancer, predicts response to tamoxifen or other anti-estrogens, only weakly associated with prognosis
    • However, compared to ER, PR staining adds only a limited amount of additional predictive information for response to hormonal therapy (Mod Pathol 2004;17:1545)
  • For metastatic tumors with unknown primary, relatively specific for breast origin (but numerous exceptions)
  • Often discordance between staining in core biopsies versus resections (Ann Oncol 2009;20:1948)
Microscopic (histologic) images

Contributed by Andrey Bychkov, M.D., Ph.D.

Breast, mucinous carcinoma

Missing Image

Breast, invasive ductal carcinoma

Missing Image

Cervix, metastatic breast cancer

Missing Image

Kidney, mixed epithelial & stromal tumor

Missing Image

Uterus, endometrial polyp

Images hosted on other servers:
Missing Image

Bladder, metastatic breast cancer

Missing Image

Breast: invasive ductal carcinoma

Missing Image

Uterus, endometrial stromal sarcoma

Missing Image Missing Image Missing Image

Uterus (left to right): leiomyoma, atypical leiomyoma, STUMP

Positive staining - normal
  • Breast epithelial cells, Toker cells; endocervical epithelial cells
Positive staining - disease
  • Breast: fibroadenoma (stromal cells), myofibroblastoma, phyllodes tumors (epithelial cells), pseudoangiomatous stromal hyperplasia
  • Breast carcinoma (usually well differentiated tumors, lobular, mucinous/colloid, sebaceous); endometrial adenocarcinoma (75-96%)
  • Cervical carcinoma: endometrioid, minimal deviation
  • Endometriosis (glands and stroma)
  • Kidney: mixed epithelial and stromal tumor
  • Liver: biliary cystadenoma (stroma), hepatic adenoma
  • Lymphangiomyomatosis
  • Ovarian tumors: endometrioid, ependymoma, fibroma, granulosa cell (juvenile), mucinous borderline-endocervical type; serous (50%)
  • Soft tissue aggressive angiomyxoma, angiomyofibroblastoma, cellular angiofibroma
  • Solitary fibrous tumor
  • Uterus: endometrial carcinoma, endometrial stromal tumors, leiomyoma, STUMP (Diagn Pathol 2012;7:1)
Negative staining
  • Breast: apocrine metaplasia and carcinomas, microglandular adenosis, myoepithelium and myoepithelial tumors
  • Breast carcinomas-various (triple negative, including adenosquamous, basal-like, BRCA1-related, medullary, metaplastic; also lipid-rich)
  • Endocervical adenocarcinoma, ovarian clear cell carcinoma
  • Salivary gland intraductal and other carcinomas
  • Soft tissue: fibromastosis
  • Uterus: serous carcinoma
Back to top
Image 01 Image 02